Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Glaukos (GKOS) EBT (2016 - 2025)

Historic EBT for Glaukos (GKOS) over the last 12 years, with Q3 2025 value amounting to -$16.0 million.

  • Glaukos' EBT rose 2465.62% to -$16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$89.1 million, marking a year-over-year increase of 4177.32%. This contributed to the annual value of -$147.8 million for FY2024, which is 696.28% down from last year.
  • Per Glaukos' latest filing, its EBT stood at -$16.0 million for Q3 2025, which was up 2465.62% from -$19.4 million recorded in Q2 2025.
  • In the past 5 years, Glaukos' EBT registered a high of $6.4 million during Q3 2021, and its lowest value of -$50.2 million during Q2 2024.
  • Moreover, its 5-year median value for EBT was -$27.3 million (2022), whereas its average is -$25.9 million.
  • In the last 5 years, Glaukos' EBT surged by 13866.08% in 2021 and then plummeted by 70012.27% in 2023.
  • Glaukos' EBT (Quarter) stood at -$24.3 million in 2021, then tumbled by 39.9% to -$34.0 million in 2022, then dropped by 20.99% to -$41.2 million in 2023, then grew by 12.8% to -$35.9 million in 2024, then surged by 55.47% to -$16.0 million in 2025.
  • Its EBT was -$16.0 million in Q3 2025, compared to -$19.4 million in Q2 2025 and -$17.8 million in Q1 2025.